(Q35536245)

8 August 2017

Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life (English)

1 reference

8 August 2017

1 reference

1 reference

1 reference

H Thorpe

13

0 references

author name string

S G Spiro

1

1 reference

8 August 2017

R M Rudd

2

1 reference

8 August 2017

R L Souhami

3

1 reference

8 August 2017

J Brown

4

1 reference

8 August 2017

D J Fairlamb

5

1 reference

8 August 2017

N H Gower

6

1 reference

8 August 2017

L Maslove

7

1 reference

8 August 2017

R Milroy

8

1 reference

8 August 2017

V Napp

9

1 reference

8 August 2017

M K B Parmar

10

1 reference

8 August 2017

M D Peake

11

1 reference

8 August 2017

R J Stephens

12

1 reference

8 August 2017

D A Waller

14

1 reference

8 August 2017

P West

15

1 reference

8 August 2017

Big Lung Trial participants

16

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

8 August 2017

1 reference

8 August 2017

59

1 reference

8 August 2017

10

1 reference

8 August 2017

828-836

1 reference

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

8 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746842

Recruitment of patients with lung cancer into a randomised clinical trial: experience at two centres. On behalf of the Big Lung Trial Steering Committee

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746842

Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746842

Interpreting the significance of changes in health-related quality-of-life scores.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746842

The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746842

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746842

Assessment of quality of life in small-cell lung cancer using a Daily Diary Card developed by the Medical Research Council Lung Cancer Working Party

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746842

Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746842

The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746842

Do all patients with advanced non-small-cell lung cancer benefit from cisplatin-based combination therapy?

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746842

Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a Phase II trial in patients with metastatic nonsmall cell lung carcinoma .

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746842

Chemotherapy versus best supportive care in stage IV non-small cell lung cancer, non metastatic to the brain

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746842

Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746842

Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial. Joint Lung Cancer Study G

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1746842

Cancer patients' attitudes toward treatment options for advanced non-small cell lung cancer: implications for patient education and decision support

26 September 2018

1 reference

12 December 2020

Patterns of initial management of lung cancer in the Republic of Ireland: a population-based observational study

1 reference

12 December 2020

Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer

1 reference

12 December 2020

The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials

1 reference

12 December 2020

1 reference

12 December 2020

The cost-effectiveness of navelbine alone or in combination with cisplatin in comparison to other chemotherapy regimens and best supportive care in stage IV non-small cell lung cancer

1 reference

12 December 2020

Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1136/THX.2003.020164

1 reference

8 August 2017

1 reference

8 August 2017

1 reference